一种个性化的疫苗,结合了免疫细胞死亡诱导的细胞和纳米抗原,以增强抗瘤免疫力
Ying Yang1, Peng Zheng2, Biao Duan3
1Laboratory of Molecular Immunology, Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, No.935 Jiaoling Road, Kunming 650118, China; Cell Biology & Molecular Biology Laboratory of Experimental Teaching Center, Faculty of Basic Medical Science, Kunming Medical University, Chunrong West Road, Kunming 650500, China.
这项研究开发了一种新的瘤疫苗,将免疫细胞死亡 (ICD) 与纳米抗原结合起来. 这种策略增强了抗瘤免疫力,并显著抑制了瘤生长,为癌症疫苗提供了有前途的方法.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 瘤疫苗旨在刺激对癌症的免疫反应,但面临着诸如低抗原免疫性和瘤异质性等挑战.
- 由于免疫抑制瘤微环境,现有的瘤疫苗往往难以实现有效和持续的抗瘤效果.
研究的目的:
- 开发一种使用免疫细胞死亡 (ICD) 和纳米抗原来增强抗瘤免疫力的联合疫苗策略.
- 调查ICD诱导剂和针对已建立瘤的向纳米疫苗的协同作用.
主要方法:
- 利用线粒激素 (MTX) 和黄素 (Cur) 的组合在TC-1瘤细胞中诱导ICD,评估"找到我"和"吃我"信号的释放.
- 在体内使用ICD诱导的瘤细胞与E7-HBcAg VLPs或E7-Q11纳米纤维相结合.
- 在已建立的瘤中评估了效应细胞反应和瘤生长抑制.
主要成果:
- 与单个药物相比,MTX和Cur联合治疗显著增强了瘤细胞中的ICD特性.
- ICD细胞和纳米疫苗的组合诱导了强大的抗原特异性和广泛的免疫反应.
- 这种联合策略在体内显著抑制了已建立的瘤生长.
结论:
- ICD细胞和纳米抗原的组合显示出协同作用的抗瘤效应.
- 这种方法引起了全面的抗瘤免疫力,为开发有效的个性化瘤疫苗提供了一个有希望的战略.
更多相关视频
07:33Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
Published on: September 28, 2022
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
相关概念视频
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Vaccinations
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
